| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $120,055,754 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI189586 | Development of HTS for discovery of IL-25 inhibitors | 000 | 1 | NIH | 2/6/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA300362 | Effects of combined FAK inhibition with MAPK blockade in brain metastases from cutaneous melanoma | 001 | 1 | NIH | 3/31/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA300362 | Effects of combined FAK inhibition with MAPK blockade in brain metastases from cutaneous melanoma | 000 | 1 | NIH | 3/27/2026 | $634,900 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30HD118749 | Image-Based Modeling of Pediatric Charcot-Marie-Tooth Disease Relative to Neuromuscular Development and Treatment | 001 | 1 | NIH | 2/4/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30HD118749 | Image-Based Modeling of Pediatric Charcot-Marie-Tooth Disease Relative to Neuromuscular Development and Treatment | 000 | 1 | NIH | 2/4/2026 | $54,538 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30HD118749 | Image-Based Modeling of Pediatric Charcot-Marie-Tooth Disease Relative to Neuromuscular Development and Treatment | 002 | 1 | NIH | 4/1/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI196901 | Dissecting T Cell Developmental Defects in Down Syndrome | 000 | 1 | NIH | 1/30/2026 | $454,482 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM162026 | Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical Research | 000 | 1 | NIH | 3/2/2026 | $500,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI197490 | Cholesterol Metabolism in Regulatory T cell Function | 000 | 1 | NIH | 1/30/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM162610 | Investigating the biological functions, biosynthesis, and dynamic regulations of RNA chemical modifications | 000 | 1 | NIH | 3/3/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00DA059957 | Cross-region neural mechanisms that support conditioned taste aversion | 000 | 3 | NIH | 1/21/2026 | $249,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K99CA307604 | Harnessing Androgen-Driven Immune Modulation to Enhance Immunotherapy for Endocrine Cancers | 000 | 1 | NIH | 4/29/2026 | $126,933 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K08CA252883 | Mechanisms of resistance to MEK Inhibition in RAS-pathway activated chronic myelomonocytic leukemia | 000 | 5 | NIH | 4/21/2026 | $289,908 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA176839 | Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy | 000 | 9 | NIH | 4/17/2026 | $385,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR082973 | Contribution of the NOD/RIPK2 signaling pathway to osteoarthritis susceptibility | 000 | 3 | NIH | 4/8/2026 | $525,081 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30AI191743 | Directed evolution of a nascent immune function | 001 | 1 | NIH | 4/2/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30AI191743 | Directed evolution of a nascent immune function | 002 | 1 | NIH | 4/2/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30AI191743 | Directed evolution of a nascent immune function | 000 | 1 | NIH | 3/27/2026 | $40,547 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH132822 | Prefrontal Circuit Control of Isolation-Induced Aggression | 000 | 4 | NIH | 2/11/2026 | $584,687 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23HL157751 | A theory-based practice guide for creating patient education | 000 | 5 | NIH | 2/26/2026 | $149,623 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R13HD079163 | PRS Young Investigators Grants Workshop | 000 | 13 | NIH | 1/22/2026 | $10,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS140319 | Overcoming Therapy Resistance in Hedgehog Pathway-Driven Medulloblastoma | 000 | 2 | NIH | 6/5/2026 | $611,591 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG083580 | Geriatric assessment domains in relation to treatment outcomes among older adults with colorectal cancer | 000 | 3 | NIH | 4/9/2026 | $765,362 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UH3NS132134 | A reference-free computational algorithm for comprehensive somatic mosaic mutation detection | 000 | 4 | NIH | 3/25/2026 | $615,585 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EB038025 | Binding-Induced Enzyme Activation for Prodrug Therapy of HER2 Variants | 000 | 2 | NIH | 5/7/2026 | $346,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K24AG080168 | Using pharmacoepidemiology to optimize antihypertensive medication use to prevent aging-related multimorbidity: Midcareer investigator award in patient-oriented research and mentoring. | 000 | 4 | NIH | 2/17/2026 | $198,213 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23EY032577 | Improving Glaucoma Care Using a Scalable Decision Support System | 000 | 5 | NIH | 4/6/2026 | $270,321 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00MH121563 | Determining the role of amygdalostriatal transition zone circuits in associative learning and motivated behaviors | 000 | 5 | NIH | 3/6/2026 | $249,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HG012286 | Calypso: a web software system supporting team-based, longitudinal genomic diagnostic care | 000 | 5 | NIH | 1/2/2026 | $887,934 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR083990 | Novel Zinc-Finger Protein Regulator of Senescence and Cell Engineering | 000 | 3 | NIH | 5/19/2026 | $369,818 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NR020784 | A Novel mHealth Intervention to Improve Outcomes of Children with Medical Complexity | 001 | 3 | NIH | 3/26/2026 | $608,267 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31AI200431 | Unraveling the role of trisomy in Down Syndrome-dependent thymic development | 000 | 1 | NIH | 6/9/2026 | $38,554 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA302892 | Generation of syngeneic, mutation-driven melanomas in an autoimmune-prone mouse to improve therapeutic efficacy without immunotoxicity | 000 | 1 | NIH | 5/26/2026 | $635,581 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01GM160384 | Regulation of single cell migration in vivo | 000 | 1 | NIH | 5/26/2026 | $392,942 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA305900 | A Patient-Specific Magnetic Resonance Guided Focused Ultrasound System for Breast Cancer Treatment | 000 | 1 | NIH | 5/28/2026 | $625,791 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R03HL183281 | Lung megakaryocytes and lung megakaryocyte-derived platelets contribute to lung injury | 000 | 1 | NIH | 5/28/2026 | $231,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31AI200271 | Dysregulation of Aging Regulatory T-Cell Response in Autoimmune Disease | 000 | 1 | NIH | 5/28/2026 | $38,914 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21MH138856 | Isoform-Specific LEF1 Function in Hypothalamic Neurogenesis and Behavior | 000 | 1 | NIH | 4/17/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00NS137249 | Basal Ganglia Network Neurophysiology of Depression in Parkinson’s Disease | 000 | 2 | NIH | 4/17/2026 | $248,333 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23DK143313 | Implementing Social Drivers of Health Screening and Interventions to Reduce Health Disparities in Chronic Liver Disease | 000 | 1 | NIH | 3/19/2026 | $210,189 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31ES038448 | Air pollution mixtures and pregnancy: assessing exposure, estimating risk, and predicting susceptibility with machine learning | 000 | 1 | NIH | 4/8/2026 | $44,201 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31ES038448 | Air pollution mixtures and pregnancy: assessing exposure, estimating risk, and predicting susceptibility with machine learning | 001 | 1 | NIH | 5/6/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00GM155552 | The regulatory landscape of segmentally duplicated genes: Implications for human evolution and disease | 000 | 3 | NIH | 1/9/2026 | $248,965 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21MH140335 | Elucidating the Role of the Hippocampus in Motor Memory using Temporal Interference Stimulation | 000 | 1 | NIH | 3/10/2026 | $402,802 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG097508 | Development of a Plasma Biomarker for TDP-43 Proteinopathy | 000 | 1 | NIH | 12/23/2025 | $437,252 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00GM146031 | Molecular mechanisms of ZAK- and GCN2-mediated signaling in response to ribotoxic stress | 000 | 3 | NIH | 1/26/2026 | $249,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32MH140490 | Influence of social environment on the neural mechanisms of sickness | 000 | 1 | NIH | 5/7/2026 | $79,348 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32MH140490 | Influence of social environment on the neural mechanisms of sickness | 001 | 1 | NIH | 5/7/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AG098947 | Decision-Making Capacity Assessment and Inclusive Decision-Making for Older Persons with Capacity Challenges | 001 | 1 | NIH | 4/24/2026 | $0 |
|
